| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 04/22/2004 | US20040077555 Substituted benzene derivatives or salts thereof |
| 04/22/2004 | US20040077547 Preventing catalytic conversion of factors X, VII AND IX to Xa, VIIa and IXa respectively |
| 04/22/2004 | US20040077042 Cell line expressing mutated human tissue-type plasminogen activator, the constructing strategy thereof and method of preparing expressed protein |
| 04/22/2004 | US20040077002 Useful in the study of vascular smooth muscle cell proliferation and in the treatment of blood vessel diseases that result from excessive smooth muscle cell proliferation, particularly after balloon angioplasty; atherosclerosis |
| 04/22/2004 | US20040076956 Oligonucleotides and/or PNA-oligomers for detecting the cytosine methylation state of genes associated with DNA repair which are directed against the sequence; ascertaining genetic and/ or epigenetic parameters of DNA repair genes |
| 04/22/2004 | US20040076673 Oral pharmaceutical composition containing a block copolymer |
| 04/22/2004 | US20040076672 For treating cancer and other angiogenic-dependent diseases, and more specifically, to compositions comprising anti-angiogenic factors and polymeric carriers, stents which have been coated with such compositions |
| 04/22/2004 | US20040076628 Use of IL-18 inhibitors for the treatment and/or prevention of atherosclerosis |
| 04/22/2004 | US20040076608 Cytokine uses; compositions; methods |
| 04/22/2004 | US20040074504 Method and composition for inhibiting cardiovascular cell proliferation |
| 04/22/2004 | CA2465860A1 Methods and compositions for therapeutic use of rna interference |
| 04/21/2004 | EP1410796A2 New therapeutic uses for potassium channel openers |
| 04/21/2004 | EP1410034A2 Methods and compositions for the treatment and prevention of smooth muscle cell proliferation |
| 04/21/2004 | EP1410018A1 Method for detecting modultators of notch signalling |
| 04/21/2004 | EP1409737A2 Methods for detecting and treating the early onset of aging-related conditions |
| 04/21/2004 | EP1409705A1 A process for the production of an inhibitor of human platelet aggregation and soybean lipoxygenase |
| 04/21/2004 | EP1409677A2 Receptors and membrane-associated proteins |
| 04/21/2004 | EP1409672A2 Antisense oligonucleotides which can inhibit the formation of capillary tubes by endothelial cells |
| 04/21/2004 | EP1409655A2 Immunoglobulin superfamily proteins |
| 04/21/2004 | EP1409645A1 Probiotic lactobacillus salivarius strains |
| 04/21/2004 | EP1409644A1 Probiotic bifidobacterium strains |
| 04/21/2004 | EP1409540A2 Melanocortin receptor ligands |
| 04/21/2004 | EP1409535A2 Human secreted proteins |
| 04/21/2004 | EP1409491A2 Thienopyrimidine-based inhibitors of the src family |
| 04/21/2004 | EP1409490A1 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta a]naphthalenyl derivatives with antipsychotic activity |
| 04/21/2004 | EP1409489A1 6-phenyldihydropyrrolopyrimidinedione derivatives |
| 04/21/2004 | EP1409488A1 Imidazo-triazine derivatives as ligands for gaba receptors |
| 04/21/2004 | EP1409479A2 1-glycinyl-4-(1-methylpiperidin-4-yl)piperazines and -piperidines as factor xa antagonists |
| 04/21/2004 | EP1409467A1 Synthesis of udp-glucose: n-acylsphingosine glucosyltransferase inhibitors |
| 04/21/2004 | EP1409463A1 N-heterocyclic inhibitors of tnf-alpha expression |
| 04/21/2004 | EP1409455A1 Prostaglandin analogues-as ep4 receptor agonists |
| 04/21/2004 | EP1409449A1 Alpha-ketoglutarates of active ingredients and compositions containing same |
| 04/21/2004 | EP1409446A1 Method for the nitration of phenolic compounds |
| 04/21/2004 | EP1409025A1 Vector encoding human globlin gene and use thereof in treatment of hemoglobinopathies |
| 04/21/2004 | EP1409010A1 Treating endotoxemia and related disorders with probiotics |
| 04/21/2004 | EP1409007A2 Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
| 04/21/2004 | EP1409005A1 Modulators of notch signalling for use in immunotherapy |
| 04/21/2004 | EP1409000A4 Use of agaricus blazei murill to prevent or treat skin and other disorders |
| 04/21/2004 | EP1409000A1 Use of agaricus blazei murill to prevent or treat skin and other disorders |
| 04/21/2004 | EP1408963A1 2- 5-(5-CARBAMIMIDOYL-1 i H /i -HETEROARYL)-6-HYDROXYBIPHENYL-3-YL]-SUCCINIC ACID DERIVATIVES AS FACTOR VIIA INHIBITORS |
| 04/21/2004 | EP1408962A1 Substituted isoindoles and the use thereof |
| 04/21/2004 | EP1408952A1 Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders |
| 04/21/2004 | EP1408950A2 Methods of treating cytokine mediated diseases |
| 04/21/2004 | EP1287355B1 Methods and compounds for influencing beta3 integrin-dependent intracellular processes |
| 04/21/2004 | EP1228039B1 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them |
| 04/21/2004 | EP1181036A4 Pharmaceutical compositions of erythropoietin |
| 04/21/2004 | EP1105370B1 Novel aryl sulphonamides and analogues |
| 04/21/2004 | EP0683781B1 Novel inhibitors of adenosine monophosphate deaminase |
| 04/21/2004 | EP0641215B1 Protease-resistant thrombomodulin analogs |
| 04/21/2004 | CN2612670Y Apparatus for preparing anticoagulant cellulose sulfate pharmaceutical |
| 04/21/2004 | CN1491208A Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical |
| 04/21/2004 | CN1491207A Acylated indanyl amines and their use as pharmaceuticals |
| 04/21/2004 | CN1491109A Medical compositions containing aspirin |
| 04/21/2004 | CN1490329A Imidazoline substituted phenoxyacetyl oligopeptide compounds, their synthesis and medical uses |
| 04/21/2004 | CN1490049A CD26/DPP IV application for medicine in preparing treatment and/or diagnostic disease |
| 04/21/2004 | CN1490040A Method for treating hypoleucocytosis |
| 04/21/2004 | CN1490038A Products as food or medicine against thrombus and cardiac and encephalic blood vessel diseases and reducing fat and their productions |
| 04/21/2004 | CN1490031A Composite donkey-hide gelatin agent and its preparation |
| 04/21/2004 | CN1146575C Peptidyl heterocycles useful in the treatment of thrombin related disorders |
| 04/21/2004 | CN1146543C Serine protease inhibitor |
| 04/21/2004 | CN1146542C Benzamide derivatives and their use as cytokine inhibitors |
| 04/21/2004 | CN1146541C Beta-alanine derivatives |
| 04/21/2004 | CN1146437C Hemopathy treating medicine |
| 04/20/2004 | US6723830 Short peptides which selectively modulate the activity of protein kinases |
| 04/20/2004 | US6723740 Administering therapeutic amount of human peroxisome proliferator activated receptor delta agonist to lower triglycerides |
| 04/20/2004 | US6723736 For therapy inflammation, inflammatory diseases, immunologic diseases and other diseases mediated by tumor necrosis factor-alpha (tnf-alpha) and/or interleukin 6 or 10 and/or enzyme cyclooxygenase-2 (cox-2) |
| 04/20/2004 | US6723723 Heterocyclic derivatives as inhibitors of factor Xa |
| 04/20/2004 | US6723525 Methods and compositions for screening modulators of lipid kinases |
| 04/20/2004 | US6723238 Blood centrifuge cup having a replaceable compartment for filter support |
| 04/15/2004 | WO2004016607B1 Inhibition of phosphoinositide 3-kinase beta |
| 04/15/2004 | WO2004014859A3 Process for preparing quinolin antibiotic intermediates |
| 04/15/2004 | WO2004002477A8 2-(phenyl)-2h-pyrazole-3-carboxylic acid-n-4-(thioxo-heterocyclyl)-phenyl-amide derivatives and corresponding imino-heterocyclyl derivatives and relates compounds for use as inhibitors of the coagulation factors xa and/or viia for treating thromboses |
| 04/15/2004 | WO2003049717A3 Conductance of improperly folded proteins through the secretory pathway and related treatments of diseases |
| 04/15/2004 | WO2003020767A9 Antibodies against caspase-8, their preparation and use |
| 04/15/2004 | WO2002000611A9 Fmoc-l-leucine and derivatives thereof as ppar-gamma agonists |
| 04/15/2004 | US20040073036 Substituted alkyl amido piperidines |
| 04/15/2004 | US20040073025 Thrombin inhibitors |
| 04/15/2004 | US20040073005 Ti-3 protein derived from triatoma infestans exhibiting activity to inhibit platelet aggregation |
| 04/15/2004 | US20040072997 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 04/15/2004 | US20040072895 Preparation of pharmaceutically acceptable atorvastatin salts in non-crystalline forms |
| 04/15/2004 | US20040072883 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 04/15/2004 | US20040072866 Condensation, dehydration; factor x inhibitors |
| 04/15/2004 | US20040072860 Piperazin-2-one amides as inhibitors of factor xa |
| 04/15/2004 | US20040072850 Caspase inhibitors and uses thereof |
| 04/15/2004 | US20040072846 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives |
| 04/15/2004 | US20040072832 Anticancer agents; antiinflammatory agents |
| 04/15/2004 | US20040072803 Novel compounds for modulating cell proliferation |
| 04/15/2004 | US20040072797 In liquid siolvent; parenterally administering; aldosterone receptors blockers; congestive heart failure, hypotensive agents, liver disorders |
| 04/15/2004 | US20040072758 Contulakin-G, analogs thereof and uses therefor |
| 04/15/2004 | US20040072238 Integrin binding polipeptide for diagnosis, prevention and treatment of renal failure, thrombosis, osteoporosis, cancers and diabetes |
| 04/15/2004 | US20040072194 Vasodilation polypeptide for diagnosis and treatment of vascular and cardiovascular system disorders |
| 04/15/2004 | US20040072188 Comprises nucleotide sequences coding B-cell activating factor receptor (BAFF-R) for diagnosis, prevention, treatment and/or delay of cancers, lymphomas and autoimmune diseases |
| 04/15/2004 | US20040072172 Comprises enzymatic polypeptide associated with calcium dependent movement of phospholipids through plasmid membranes for diagnosis and treatment of thrombosis, angina pectoris and stroke; gene therapy |
| 04/15/2004 | US20040071709 Corona-virus-like particles comprising functionally deleted genomes |
| 04/15/2004 | US20040071704 Antithrombotic von willebrand factor (vwf) collagen bridging blockers |
| 04/15/2004 | US20040071688 Reduced or removed potential T cell epitopes |
| 04/15/2004 | US20040071676 Yeast expression vector and a method of making a recombinant protein by expression in a yeast cell |
| 04/15/2004 | US20040071655 Binding agent |
| 04/15/2004 | DE10246125A1 Konzentrat eines Faktor VIII:C-haltigen von-Willebrand-Faktors und das dazu gehörige Verfahren Concentrate of factor VIII: C-containing von Willebrand factor and the associated method |
| 04/14/2004 | EP1407780A1 Pharmaceutically stable hemostatic compositions |